"non cancer cells" trang 2 - tải miễn phí từ tailieunhanh
Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein

Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein
11    85    1
All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells

All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells
9    80    0
Karyotyping of circulating tumor cells for predicting chemotherapeutic sensitivity and efficacy in patients with esophageal cancer

Karyotyping of circulating tumor cells for predicting chemotherapeutic sensitivity and efficacy in patients with esophageal cancer
7    57    0
Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells

Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells
13    65    1
Phenethyl isothiocyanate upregulates death receptors 4 and 5 and inhibits proliferation in human cancer stem-like cells

Phenethyl isothiocyanate upregulates death receptors 4 and 5 and inhibits proliferation in human cancer stem-like cells
12    29    1
Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression

Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression
14    46    1
MEOX1 promotes tumor progression and predicts poor prognosis in human non-small-cell lung cancer

MEOX1 promotes tumor progression and predicts poor prognosis in human non-small-cell lung cancer
7    82    0
High expression of AGR2 in lung cancer is predictive of poor survival

High expression of AGR2 in lung cancer is predictive of poor survival
9    22    1
Silencing of long-non-coding RNA ANCR suppresses the migration and invasion of osteosarcoma cells by activating the p38MAPK signalling pathway

Silencing of long-non-coding RNA ANCR suppresses the migration and invasion of osteosarcoma cells by activating the p38MAPK signalling pathway
9    71    0
S100A4 suppresses cancer stem cell proliferation via interaction with the IKK/NF-κB signaling pathway

S100A4 suppresses cancer stem cell proliferation via interaction with the IKK/NF-κB signaling pathway
7    32    1
IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts

IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts
13    75    1
The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFRmutated and -wildtype non-small cell lung cancer cells

The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFRmutated and -wildtype non-small cell lung cancer cells
10    57    1
A novel naproxen derivative capable of displaying anti-cancer and anti-migratory properties against human breast cancer cells

A novel naproxen derivative capable of displaying anti-cancer and anti-migratory properties against human breast cancer cells
8    58    1
Concurrent chemoradiotherapy with tomotherapy in locally advanced non-small cell lung cancer: A phase i, docetaxel dose-escalation study, with hypofractionated radiation regimen

Concurrent chemoradiotherapy with tomotherapy in locally advanced non-small cell lung cancer: A phase i, docetaxel dose-escalation study, with hypofractionated radiation regimen
7    59    1
Potentiation of in vitro and in vivo antitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276-00 in human non-small cell lung cancer cells

Potentiation of in vitro and in vivo antitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276-00 in human non-small cell lung cancer cells
10    37    1
The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy

The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy
11    47    1
A phase I/II clinical trial on the efficacy and safety of NKT cells combined with gefitinib for advanced EGFR-mutated non-small-cell lung cancer

A phase I/II clinical trial on the efficacy and safety of NKT cells combined with gefitinib for advanced EGFR-mutated non-small-cell lung cancer
8    28    1
EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation

EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation
13    32    1
Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-κB axis

Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-κB axis
13    20    1
Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression

Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression
11    49    1